Mkts

Aurinia Pharmaceuticals Inc

NASDAQ: AUPH
$15.13-0.27 (-1.75%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
15.0515.46
52-week range
13.5219.25
Today
Open15.30
Previous close15.13
Volume—
Valuation
Market cap2.03B
P/E ratio6.45×
EPS (TTM)2.29
Income & risk
Dividend / yield—
Beta1.31
Avg volume949.8K
Discussion

AUPH News

Stories mentioning AUPH from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue77,70577,11473,46870,00862,46559,86767,77157,192
Cost of Goods Sold6,5058,7998,1777,1158,5745,5526,0358,909
Gross Profit71,20068,31565,29162,89353,89154,31561,73648,283
Operating Expenses
Research & Development7,47010,8958,4357,4325,7438,1073,0474,080
Sales General & Admin
Total Operating Expenses43,87543,72349,92540,61861,53656,02358,705
Operating Income (Loss)41,42233,23929,74520,08321,847(1,669)11,748(1,513)
Interest Income3,5153,4983,3163,1903,5693,9884,2674,189
Interest Expense1,198
Other Expense
Pretax Income43,92535,69031,96222,15624,3491,17314,8071,478
Tax Provision9,570(175,104)411.00643.001,005(256.00)457.00756.00
Net Income (Loss)34,355210,79431,55121,51323,3441,42914,350722.00
Earnings Per Share (Basic)0.261.600.240.160.170.010.100.01
Earnings Per Share (Diluted)0.251.530.230.160.160.010.100.01
Weighted Average Shares Outstanding (Basic)132,375134,367131,808134,873138,917143,057143,051143,327
Weighted Average Shares Outstanding (Diluted)137,639138,700136,008137,526143,199146,194145,651144,110

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AUPH

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol AUPH. It last traded at $15.13 (Nov 18, 2026, 4:00 PM ET), down 1.8% on the day. That gives Aurinia Pharmaceuticals a market capitalisation of $2.0B and a price-to-earnings ratio of 6.5.

Over the past 52 weeks AUPH has traded between $13.52 and $19.25.

Revenue for the quarter ended Mar 31, 2026 was $77.7M; net income $34.4M. Revenue was up 24.4% from $62.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$77.7M$34.4M44.2%
Dec 31, 2025$77.1M$210.8M273.4%
Sep 30, 2025$73.5M$31.6M42.9%
Jun 30, 2025$70.0M$21.5M30.7%

From Aurinia Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…